ArticlePLOS global public health2025
Determinants of COVID-19 vaccine uptake among persons with disabilities in three selected districts of Zambia.
Article in PLOS global public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
COVID-19, is still a public health threat due to uncertainties around the potential evolution of the virus, changes in clinical characteristics, and the introduction of new prevention and therapeutic modalities. Persons with Disabilities (PWDs) were among the most highly affected groups by the COVID-19 pandemic due to their underlying conditions. This study aimed to establish the prevalence and identify the determinants of COVID-19 vaccine uptake among PWDs in three selected districts of Zambia. A cross-sectional study was conducted from June to August 2023 in Lusaka, Mazabuka, and Monze Districts. Structured questionnaires were developed and administered to PWDs aged 18 years and above. Log-binomial model was used to calculate the adjusted prevalence ratios (aPRs) and 95% confidence intervals (CIs) for assessing COVID-19 vaccine acceptance and its determinants. Out of the sample of 985, the proportion of COVID-19 vaccine uptake was 67.6% (95% CI: 65%, 71%). Vaccine uptake was higher among the married (aPR: 1.21; 95% CI:1.06, 1.39) participants from Mazabuka District (aPR: 1.61; 95% CI: 1.34, 1.93) living in rural areas (aPR:1.27; 95% CI: 1.09, 1.49) having extra income (aPR:1.27; 95% CI: 1.09,1.50) involved in routine health checkup (aPR:1.23; 95% CI: 1.11, 1.37) previously infected with COVID-19 (aPR:1.32; 95% CI, 1.04-1.68) previously vaccinated (aPR: 1.16; 95% CI: 1.00, 1.33) and understanding safety of the vaccine (aPR: 2.33; 95% CI: 1.55, 3.49). Conversely, low vaccine uptake was observed among participants earning less than k200 from social cash transfer (aPR: 0.79; 95% CI: 0.71, 0.87). More research is needed to identify determinants of vaccine uptake among PWDs that make them more vulnerable to infectious diseases such as COVID-19. There is need to improve vaccination coverage among PWDs. A more holistic and inclusive health promotion approach needs to be adopted to ensure that PWDs are not left behind in accessing vaccines.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.